Nom du produit:2-Chloromethyl-5-trifluoromethyl-benzothiazole
IUPAC Name:2-(chloromethyl)-5-(trifluoromethyl)-1,3-benzothiazole
- CAS:110704-50-2
- Formule moléculaire:C9H5ClF3NS
- Pureté:95%
- Numéro de catalogue:CM157389
- Poids moléculaire:251.65
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:110704-50-2
- Formule moléculaire:C9H5ClF3NS
- Point de fusion:-
- Code SMILES:FC(C1=CC=C(SC(CCl)=N2)C2=C1)(F)F
- Densité:
- Numéro de catalogue:CM157389
- Poids moléculaire:251.65
- Point d'ébullition:
- N° Mdl:MFCD11040746
- Stockage:Store at 2-8°C.
Category Infos
- Benzothiazoles
- Benzothiazoles are aromatic heterocyclic compounds with the chemical formula C7H5NS. Benzothiazoles and their derivatives are a very important class of heterocyclic compounds that are ubiquitous in nature and are mainly used in medicine, agriculture and industry. In medicine, benzothiazole derivatives are a kind of very important pharmaceutical intermediates with good pharmacological and biological activities. It can be used as a fungicide, anti-tuberculosis drug, anti-malarial, anti-convulsant, insecticide, sedative and anti-inflammatory drug, and can also be used to treat diabetes and has anti-cancer effects.
Column Infos
- Govorestat
- Applied Therapeutics announced FDA acceptance and priority review of new drug application for Govorestat for the treatment of classic galactosemia. Govorestat is a central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) in development for the treatment of several rare neurological diseases, including Galactosemia, SORD Deficiency, and PMM2-CDG.